Home Page

Our Company

The Ann Arbor Pharmacometrics Groups (A2PG) is a functional service provider specializing in model-based drug development consulting for the pharmaceutical industry. Our consulting services include population pharmacokinetic and pharmacodynamic (pop PK/PD) modeling and model-based clinical trial simulations to support trial designs, program strategy and decision-making.

Our Vision

To promote leveraging information across Statistics, Clinical, and Pharmacokinetic/Pharmacodynamic disciplines through the application of models and clinical trial simulation techniques in order to enhance drug development strategies and decision-making -- i.e., model based drug development (MBDD).

To learn more about our vision and model-based drug development activities, review each of the model-based drug development components in the diagram above by clicking on each component (hexagon) beginning with the center component.